The world’s leading biopharma and medtech companies trust BrightInsight as their regulated IoT platform, supporting transformational digital health solutions including Software as a Medical Device, connected combination products, apps and more.
"We selected BrightInsight because its pre-built, compliant platform accelerates our time to market while allowing us to focus on digital health innovation and leveraging our clinical know-how to improve patient outcomes instead of the underlying infrastructure."
Karan Arora, Chief Commercial Digital Officer and Global Vice President, AstraZeneca
Learn More
"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."
Brian Johnson, Director, Digital Health, CSL Behring
Learn More
"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."
Anders Dyhr Toft, Corporate Vice President, Commercial Innovation, Novo Nordisk
Learn More
"If you leverage a solution like BrightInsight that meets the most stringent requirements and maintains compliance as part of their managed service, you don’t have to worry about your regulated digital solutions in the U.S. versus Europe versus U.K. and so on. You just know they’re compliant."
Paul Upham, Head of Smart Devices, Roche/Genentech
Learn More
Whether it’s personalized patient engagement analytics, market intelligence on drug and device usage, or building blocks for patient-facing apps, our BrightInsight Platform offers comprehensive solutions that can improve patient adherence.
Request a DemoThe biopharma industry faces escalating pressure on pricing transparency and reimbursement.
By integrating drug and device data from multiple sources, while working seamlessly with existing EMR and other IT systems, our BrightInsight Platform provides compelling analytics that can demonstrate improved outcomes.
Learn More
Today it takes between ten and fifteen years to bring a new drug to market. McKinsey estimates that big data can help generate $100 billion in value across the U.S. healthcare system by accelerating clinical trials and optimizing R&D activities.
BrightInsight’s real-world data can help deliver on that promise, cutting trial timelines, while improving data accuracy. Our device-agnostic platform also supports inclusion of off-the-shelf and custom medical devices in clinical trials.
DownloadRoche collaborates with BrightInsight, built on Google Cloud, to build a regulated digital health solution for improving patient care.
Listen to our webinar featuring Roche and Google Cloud executives.
Webinar